Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.750
-0.370 (-11.86%)
Jun 23, 2026, 4:00 PM EDT - Market closed
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $14.67 million as of June 23, 2026. Its market cap has increased by 54.47% in one year.
Market Cap
14.67M
Enterprise Value
4.36M
1-Year Change
54.47%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $14.67M, a decrease of -79.24%. That is a compound annual growth rate of -14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 14.70M | 119.40% |
| Dec 31, 2025 | 6.70M | 31.37% |
| Dec 31, 2024 | 5.10M | -80.08% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
| Jun 2, 2016 | 70.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 18.01M |
| Werewolf Therapeutics | 17.99M |
| GT Biopharma | 17.69M |
| CEL-SCI | 17.65M |
| Exicure | 17.46M |
| AEON Biopharma | 17.34M |
| Curis | 17.11M |
| Moolec Science | 16.62M |